Overview

Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of AL-39256 in patients with open-angle glaucoma or ocular hypertension.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Latanoprost
Ophthalmic Solutions
Criteria
Inclusion Criteria:

- Diagnosed with open-angle glaucoma or ocular hypertension.

- Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

- Females of childbearing potential.

- Other protocol-defined exclusion criteria may apply.